Over the past ninety days, The Precision Peptide Company Inc. recorded three insider trading transactions, all involving director Pratapvir Sandhu. These acquisitions totaled 166,725 CAD in value. No sales occurred during this period, reflecting exclusively purchasing activity by a single board member across multiple dates in June and July.